Relationships Between Human-Extracted MRI Tumor Phenotypes of Breast Cancer and Clinical Prognostic Indicators Including Receptor Status and Molecular Subtype.
暂无分享,去创建一个
E. Burnside | M. Giger | K. Brandt | A. Rao | M. Ganott | M. Zuley | G. Whitman | E. Sutton | J. Net | Elizabteh Morris | Elizabeth Morris
[1] Steven Sourbron,et al. Deconvolution-based dynamic contrast-enhanced MR imaging of breast tumors: correlation of tumor blood flow with human epidermal growth factor receptor 2 status and clinicopathologic findings--preliminary results. , 2008, Radiology.
[2] R. Fisher. On the Interpretation of χ2 from Contingency Tables, and the Calculation of P , 2010 .
[3] A. Giuliano,et al. Personalizing breast cancer staging by the inclusion of ER, PR, and HER2. , 2014, JAMA surgery.
[4] Maryellen Giger,et al. Computerized three-class classification of MRI-based prognostic markers for breast cancer , 2011, Physics in medicine and biology.
[5] C. Perou,et al. Genomics, prognosis, and therapeutic interventions , 2014 .
[6] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[7] Lars J. Grimm,et al. Computational approach to radiogenomics of breast cancer: Luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms , 2015, Journal of magnetic resonance imaging : JMRI.
[8] A. Nobel,et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] E. Morris. Diagnostic breast MR imaging: current status and future directions. , 2007, Radiologic clinics of North America.
[10] Lorenzo Bonomo,et al. Magnetic resonance imaging features in triple-negative breast cancer: comparison with luminal and HER2-overexpressing tumors. , 2012, Clinical breast cancer.
[11] Neema Jamshidi,et al. Breast Cancer: Radiogenomic Biomarker Reveals Associations among Dynamic Contrast-enhanced MR Imaging, Long Noncoding RNA, and Metastasis. , 2015, Radiology.
[12] Stephen M. Moore,et al. The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository , 2013, Journal of Digital Imaging.
[13] Steven J. M. Jones,et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer , 2015, Cell.
[14] R. Fisher. 019: On the Interpretation of x2 from Contingency Tables, and the Calculation of P. , 1922 .
[15] M. Noguchi,et al. Two different types of ring‐like enhancement on dynamic MR imaging in breast cancer: Correlation with the histopathologic findings , 2008, Journal of magnetic resonance imaging : JMRI.
[16] Eun-Kyung Kim,et al. Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes , 2012, European Radiology.
[17] Li Lan,et al. Computerized assessment of breast lesion malignancy using DCE-MRI robustness study on two independent clinical datasets from two manufacturers. , 2010, Academic radiology.
[18] L. Carey,et al. Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy. , 2009, Seminars in radiation oncology.
[19] Erich P Huang,et al. Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set , 2016, npj Breast Cancer.
[20] A Horsman,et al. Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging. , 1997, Radiology.
[21] S. Jeffrey,et al. Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression. , 2008, Radiology.
[22] A. Madabhushi,et al. Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility study. , 2014, Radiology.
[23] Monica Morrow,et al. Presenting Features of Breast Cancer Differ by Molecular Subtype , 2009, Annals of Surgical Oncology.
[24] Eric M Blaschke,et al. MRI phenotype of breast cancer: Kinetic assessment for molecular subtypes , 2015, Journal of magnetic resonance imaging : JMRI.
[25] Erich P Huang,et al. Using computer‐extracted image phenotypes from tumors on breast magnetic resonance imaging to predict breast cancer pathologic stage , 2016, Cancer.
[26] Erich P Huang,et al. MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays. , 2016, Radiology.
[27] J. Pietenpol,et al. Identification and use of biomarkers in treatment strategies for triple‐negative breast cancer subtypes , 2014, The Journal of pathology.
[28] G. Newstead,et al. Intratumoral heterogeneity of the distribution of kinetic parameters in breast cancer: comparison based on the molecular subtypes of invasive breast cancer , 2015, Breast Cancer.
[29] Janet Waters,et al. MRI for breast cancer screening, diagnosis, and treatment , 2011, The Lancet.
[30] N. Graham,et al. Areas beneath the relative operating characteristics (ROC) and relative operating levels (ROL) curves: Statistical significance and interpretation , 2002 .
[31] W. Kruskal,et al. Use of Ranks in One-Criterion Variance Analysis , 1952 .
[32] H. Lehr,et al. Dynamic MR imaging of breast lesions: correlation with microvessel distribution pattern and histologic characteristics of prognosis. , 2006, Radiology.
[33] M. Giger,et al. Volumetric texture analysis of breast lesions on contrast‐enhanced magnetic resonance images , 2007, Magnetic resonance in medicine.
[34] Megumi Jinguji,et al. Rim enhancement of breast cancers on contrast-enhanced MR imaging: Relationship with prognostic factors , 2006, Breast cancer.
[35] Daniel L. Rubin,et al. The National Cancer Informatics Program (NCIP) Annotation and Image Markup (AIM) Foundation Model , 2014, Journal of Digital Imaging.
[36] Barbara L. Smith,et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] Wei Tse Yang,et al. Identification of Intrinsic Imaging Phenotypes for Breast Cancer Tumors: Preliminary Associations with Gene Expression Profiles , 2015 .
[38] M. Giger,et al. Breast image analysis for risk assessment, detection, diagnosis, and treatment of cancer. , 2013, Annual review of biomedical engineering.
[39] Daniel L. Rubin,et al. Dynamic contrast-enhanced MRI-based biomarkers of therapeutic response in triple-negative breast cancer. , 2013, Journal of the American Medical Informatics Association : JAMIA.
[40] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumours , 2013 .
[41] Lars J. Grimm,et al. Can breast cancer molecular subtype help to select patients for preoperative MR imaging? , 2015, Radiology.
[42] Eun Sook Ko,et al. Apparent diffusion coefficient in estrogen receptor-positive invasive ductal breast carcinoma: correlations with tumor-stroma ratio. , 2014, Radiology.
[43] M. Giger,et al. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI. , 2006, Medical physics.
[44] D. D. Maki,et al. Radiogenomic analysis of breast cancer using MRI: a preliminary study to define the landscape. , 2012, AJR. American journal of roentgenology.
[45] M. Giger,et al. Deciphering Genomic Underpinnings of Quantitative MRI-based Radiomic Phenotypes of Invasive Breast Carcinoma , 2015, Scientific Reports.
[46] S. O'toole,et al. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] M. Giger,et al. Computerized interpretation of breast MRI: investigation of enhancement-variance dynamics. , 2004, Medical physics.
[48] Ahmed Bilal Ashraf,et al. Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles. , 2014, Radiology.
[49] T. Nielsen,et al. Breast cancer subtypes and the risk of local and regional relapse. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[50] M. Giger,et al. Cancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers. , 2010, Radiology.
[51] Maciej A Mazurowski,et al. Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging. , 2014, Radiology.
[52] Maryellen L. Giger,et al. Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data , 2015, Journal of medical imaging.
[53] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[54] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .